Dialysis-Less Frequently In The Elderly
D-LITE
1 other identifier
interventional
49
1 country
1
Brief Summary
Thrice-weekly dialysis is the accepted standard of care for hemodialysis (HD) patients. Observational studies suggest that elderly HD patients do as well and have better quality of life with less dialysis (ie twice-weekly). We propose a single-center pilot study of 40 patients to determine the feasibility of a large randomized controlled trial (RCT) designed to determine the impact of HD frequency on well-being in new HD patients above the age of 70. The primary outcomes will be metrics of feasibility and safety. We hypothesize that an adequately powered RCT that will determine whether elderly patients who dialyze twice weekly have improved well-being compared to thrice-weekly is feasible
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2018
CompletedFirst Submitted
Initial submission to the registry
December 11, 2018
CompletedFirst Posted
Study publicly available on registry
December 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2023
CompletedMay 1, 2024
April 1, 2024
5.2 years
December 11, 2018
April 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment
Successful recruitment will be defined as \>3-4 patients/month over 12 months providing informed consent and meeting criteria for randomization.
1 year
percent of prescribed treatments completed by patient
Successful adherence will be defined as =\> 90% of intervention being adhered to.
1 year
Loss to trial completion
Successful loss to trial completion will be defined as = \>50% of randomized patients completing the 12 month trial. Based on our data, the anticipated reasons for loss to trial completion will be death and moving away from the study center.
1 year
Percent of weekly potassium values falling within normal range.
Potassium will be measured every week for the duration of the study.
1 year
Percent of weekly post hemodialysis weights that are within 1 kg of prescribed dry weight
Prescribed and acheived post HD weight will be recorded weekly.
1 year
Secondary Outcomes (1)
Change in Patient's Quality of Life - Using Edmonton Symptom Assessment System (ESAS-R)
1 year
Study Arms (2)
Twice per week dialysis
EXPERIMENTALTwice-weekly 4 hour dialysis treatment (Monday and Friday or Tuesday and Saturday).
Thrice per week dialysis
NO INTERVENTIONStandard thrice-weekly 4 hour dialysis treatment (Monday, Wednesday and Friday or Tuesday, Thursday and Staurday)
Interventions
Eligibility Criteria
You may qualify if:
- Greater than equal 70 years old, planned ongoing in-center HD treatment
- Incident HD patient and still alive 7 weeks post HD initiation
- Patient or substitute decision maker provide informed consent
You may not qualify if:
- Significant barriers to ascertainment of the patient-reported experience measures
- Patient currently admitted to hospital without Alternate Level of Care designation
- Patient non-adherent to dialysis prescription
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kingston Health Sciences Centre (KHSC)
Kingston, Ontario, K7L 2V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 11, 2018
First Posted
December 26, 2018
Study Start
June 27, 2018
Primary Completion
September 11, 2023
Study Completion
November 9, 2023
Last Updated
May 1, 2024
Record last verified: 2024-04